We have demonstrated that the circulating fibrocyte count is higher in patients with TAO than in healthy controls.[13] Fibrocytes express surface markers characteric of fibroblasts (collagen type 1) and hematopoietic cells (CD34 and CD45). This evidence concerns the gene PTPRC and thromboangiitis obliterans.